Synthesis and chemical reactivity of a 6-Me-3,2-hydroxypyridinone dithiazolide with primary amines: a route to new hexadentate chelators for hard metal(III) ions.

A hydroxypyridinone building block, bifunctionalized with thiazoline, has been prepared from orthogonally protected 2-(3-(benzyloxy)-4-(ethoxycarbonyl)-6-methyl-2-oxopyridin-1(2H)-yl) acetic acid. The reactivity of the dithiazolide has been explored with two primary amines, leading to the synthesis and characterization of four new hexadentate ligands. Their complexes with selected hard trivalent ions pertinent to potential molecular imaging applications have been surveyed.

[1]  M. Sodupe,et al.  3-Hydroxy-4-pyridinone derivatives as metal ion and amyloid binding agents. , 2014, Metallomics : integrated biometal science.

[2]  H. Jacobs,et al.  3,2-Hydroxypyridinone (3,2-HOPO) vinyl sulfonamide and acrylamide linkers: Aza-Michael addition reactions and the preparation of poly-HOPO chelators. , 2013, Tetrahedron letters.

[3]  Deborah I. Bunin,et al.  Analytical Methods for the Bioavailability Evaluation of Hydroxypyridinonate Actinide Decorporation Agents in Pre-Clinical Pharmacokinetic Studies , 2013 .

[4]  Sérgio M. Marques,et al.  Hydroxypyridinones as “privileged” chelating structures for the design of medicinal drugs , 2012 .

[5]  M. Francis,et al.  Multivalent, high-relaxivity MRI contrast agents using rigid cysteine-reactive gadolinium complexes. , 2011, Journal of the American Chemical Society.

[6]  Piper J. Klemm,et al.  Conjugation effects of various linkers on Gd(III) MRI contrast agents with dendrimers: optimizing the hydroxypyridinonate (HOPO) ligands with nontoxic, degradable esteramide (EA) dendrimers for high relaxivity. , 2011, Journal of the American Chemical Society.

[7]  Jide Xu,et al.  Eu(III) complexes of functionalized octadentate 1-hydroxypyridin-2-ones: stability, bioconjugation, and luminescence resonance energy transfer studies. , 2010, Inorganic chemistry.

[8]  M. Botta,et al.  Effect of a mesitylene-based ligand cap on the relaxometric properties of Gd(III) hydroxypyridonate MRI contrast agents. , 2009, Contrast media & molecular imaging.

[9]  K. Raymond,et al.  From antenna to assay: lessons learned in lanthanide luminescence. , 2009, Accounts of chemical research.

[10]  H. Sakurai,et al.  Novel 3-hydroxy-4-pyridinonato oxidovanadium(IV) complexes to investigate structure/activity relationships. , 2009, Journal of inorganic biochemistry.

[11]  Yuan Liu,et al.  Reactions of N-benzyloxycarbamate derivatives with stabilized carbon nucleophiles: a new synthetic approach to polyhydroxamic acids and other hydroxamate-containing mixed ligand systems. , 2009, The Journal of organic chemistry.

[12]  M. Botta,et al.  Highly soluble tris-hydroxypyridonate Gd(III) complexes with increased hydration number, fast water exchange, slow electronic relaxation, and high relaxivity. , 2007, Journal of the American Chemical Society.

[13]  K. Raymond,et al.  In vivo evaluation of gadolinium hydroxypyridonate chelates: initial experience as contrast media in magnetic resonance imaging. , 2005, Journal of medicinal chemistry.

[14]  W. Dehaen,et al.  The application of "click chemistry" for the decoration of 2(1H)-pyrazinone scaffold: generation of templates. , 2005, Journal of combinatorial chemistry.

[15]  M. Botta,et al.  Dendrimeric gadolinium chelate with fast water exchange and high relaxivity at high magnetic field strength. , 2005, Journal of the American Chemical Society.

[16]  V. Pierre,et al.  Next generation, high relaxivity gadolinium MRI agents. , 2005, Bioconjugate chemistry.

[17]  V. Pierre,et al.  Toward optimized high-relaxivity MRI agents: thermodynamic selectivity of hydroxypyridonate/catecholate ligands. , 2004, Inorganic chemistry.

[18]  M. Botta,et al.  Hetero-tripodal hydroxypyridonate gadolinium complexes: syntheses, relaxometric properties, water exchange dynamics, and human serum albumin binding. , 2004, Inorganic chemistry.

[19]  Jide Xu,et al.  Toward optimized high-relaxivity MRI agents: the effect of ligand basicity on the thermodynamic stability of hexadentate hydroxypyridonate/catecholate gadolinium(III) complexes. , 2003, Inorganic chemistry.

[20]  A. Cammidge,et al.  N- VS O-ALKYLATION IN 2(1H)-QUINOLINONE DERIVATIVES , 1999 .

[21]  David E Reichert,et al.  Metal complexes as diagnostic tools , 1999 .

[22]  J. Ashby.  References and Notes , 1999 .

[23]  M. Albrecht,et al.  Macrobicyclic Tris(catecholate ligand) complexes: Spectroscopy, Electrochemistry, and the Structure of K2[(H2-bicappedTRENCAM)MoO2] , 1994 .

[24]  Thomas M. Garrett,et al.  Ferric ion sequestering agents. 22. Synthesis and characterization of macrobicyclic iron(III) sequestering agents , 1991 .

[25]  T. Tanaka,et al.  Studies on 2-oxoquinoline derivatives as blood platelet aggregation inhibitors. III. N-cyclohexyl-N-(2-hydroxyethyl)-4-(1,2-dihydro-2-oxo-6-quinolyloxy)-butyramide and related compounds. , 1983, Chemical and pharmaceutical bulletin.

[26]  H. Rapoport,et al.  Polyprenylpyridinols. Synthesis of piericidin analogues. , 1977, Journal of the American Chemical Society.